Managing the long term effects of COVID-19: summary of NICE, SIGN, and RCGP rapid guideline (22 January)

Summary

As yet, no commonly agreed clinical definition of long term covid-19 exists, nor a clear definition of treatment pathway. To assist clinicians, the National Institute for Health and Care Excellence (NICE), the Scottish Intercollegiate Guidelines Network (SIGN), and the Royal College of General Practitioners (RCGP) have developed the COVID-19 rapid guideline: managing the long term effects of COVID-19. It covers care for people with signs and symptoms that continue for more than four weeks, and which developed during or after an infection consistent with covid-19, and which are not explained by alternative diagnoses.

This guide, published by the BMJ, provides a summary of the NICE, SIGN, and RCGP rapid guideline.